Gene therapy landscape
Pulled together 42 companies and charted the preclinical and clinical assets of each, segmented by approach and vector
Some takeaways:
The best biopharma M&A deals (with assets still contributing meaningfully in 2022)
I analyzed the pipeline of 27 big pharma and 27 acquired companies to find the asset-driven deals with the highest ROI
Summary below:
https://t.co/FIBwCQjthM
For your weekend listening, a new podcast that mixes conversations on translational science and cocktails, brought to you by our former Chief Editor Andy Marshall. Episode 1 recaps the @NatureConf "Cracking the Code: The Dawn of Nucleic Acid Medicines" https://t.co/yKQ12WLA4T
BREAKING: HAMAS LEADER OFFICIAL STATEMENT
RESPONSE TO ISRAEL KILLING HIS 3 SONS AND 3 GRANDKIDS
Ismail Haniyeh:
“I thank God for this honor that he bestowed upon us with the martyrdom of my three sons and some grandchildren.
With this pain and blood, we create hopes, a future, and freedom for our people, our cause, and our nation.”